Role of B cells in antigen presentation of the hepatitis B core.
about
IgE-mediated enhancement of CD4+ T cell responses in mice requires antigen presentation by CD11c+ cells and not by B cellsPreparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.Antigenic Switching of Hepatitis B Virus by Alternative Dimerization of the Capsid ProteinConstruction of prokaryotic expression system of TGF-beta1 epitope gene and identification of recombinant fusion protein immunity.High affinity mouse-human chimeric Fab against hepatitis B surface antigen.Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model.From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas.Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens.Comparative antigenicity and immunogenicity of hepadnavirus core proteins.Combinatorial approach to hepadnavirus-like particle vaccine designA modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hostsSerum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.Trachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: A preliminary approach for anti-HBV immunotherapySilica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.IgE-mediated enhancement of antibody responses: the beneficial function of IgE?A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.Oral attenuated Salmonella typhimurium vaccine against MG7-Ag mimotope of gastric cancer.An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection.Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platformAdvantages to the use of rodent hepadnavirus core proteins as vaccine platformsTotal Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.The Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion.T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particlesSerum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.Non-canonical binding of an antibody resembling a naïve B cell receptor immunoglobulin to hepatitis B virus capsids.Virus-like particles: flexible platforms for vaccine development.Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.Interaction of the hepatitis B core antigen and the innate immune system.Design of therapeutic vaccines: hepatitis B as an example.Overexpression of Fc receptor-like 1 associated with B-cell activation during hepatitis B virus infectionPotential Susceptibility Mutations in C Gene for Hepatitis B-Related Hepatocellular Carcinoma Identified by a Two-Stage Study in Qidong, China.A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.Hepatitis B Virus e Antigen Regulates Monocyte Function and Promotes B Lymphocyte Activation.Use of hepadnavirus core proteins as vaccine platforms.Hepatitis B core-based virus-like particles to present heterologous epitopes.Toward a Network Model of MHC Class II-Restricted Antigen Processing.
P2860
Q21091024-37BB5E1F-9987-497D-ABC4-8008BBB83DC6Q27308848-300F7D5F-E4BC-40E4-B635-0B61063AF940Q27675395-1D3BA5F7-5626-4F8D-8793-F2835CFDC5F6Q33231853-66A44E0A-86F0-49B4-B939-9C3F5E997281Q33232511-716A72F3-9BB1-4B19-BC12-B7A3E7B90BEBQ33338311-8642A2F2-EF30-480E-9BEE-F8BEFA3722A2Q33569555-18E91B25-A1D0-4E61-AC27-177960D6FDACQ33927327-6F4E8F3C-E4A7-4B76-84CE-84CECEF3A6F3Q33929813-B937E742-50E6-43FE-94E4-01ECBB5B287FQ34002939-12EF41BD-28B8-4348-BAFD-063F70B1784BQ34092768-34A39004-46F0-43EA-8078-95EECF2F64A5Q34092773-C5C7E033-81F8-4AFC-8F79-0B99BF5B6B22Q34261339-F35097A5-6C02-4DE5-8FFA-36BA19C93FC0Q34294206-E847A62D-C059-4935-820B-DDA80DD5025DQ34353473-66908DBF-BEC6-408A-BEC4-D7D3D0596190Q34478042-C5ACBB58-F0F7-430E-88B9-CDAC88F139DDQ34600988-3DA7124D-E56B-4868-BE98-66ACFF663BEDQ34722781-1E5105FC-89CB-467D-8B5A-0107F209BDDBQ35006090-50CD2585-FF48-485F-B554-3176A014080EQ35011130-42ABD4FD-CB1C-4914-A836-9E28B4EADE49Q35128696-BA5BA569-7C3F-434C-A162-2080D8355DFFQ35535626-746C0C69-3CEC-4590-B90D-C18A74F33F49Q35591551-D9C7D523-B065-4592-836F-41FBD7BD2313Q35663329-DF2B6B15-1212-4DBE-B3B6-FC95E193B2F0Q35675909-D335CF99-1C0C-44DE-A322-F4200F6E4C49Q35797289-E613749B-7F06-4EB5-990C-E3274FE26BCBQ36262265-8B92C70F-8382-49FE-8582-A265F628A759Q36381558-826936AB-7299-4625-B0BA-2624C2CAC34FQ36775969-40FDEF77-5F55-412A-BD63-E2D42A4DA270Q36837144-FDD4BCB6-DF43-4CD8-B02A-911EA6FC1CAAQ37163704-0F288866-4842-4E7A-AB15-6D877DA63C2EQ37200526-3C85626C-48DC-41BA-8B15-73B64C965F19Q37274697-6647AF1A-34D4-48F6-A5CB-5FE2D4F2D9C2Q37371002-25D82A4E-2CFF-4825-B337-37EDD9E6377BQ37377453-BE911742-1DB8-4E48-8C3F-7A8C6EE6A3A7Q37571503-420CDC9B-0558-415D-A0FC-F3E8FC4ED8AAQ37571886-0A95D2BD-D88E-4195-B281-97BFD314636BQ37622906-502277DA-742B-434A-ADDA-D8F0FC250970Q38081969-6878F44C-6C7D-4418-955C-89758094BF2BQ38174882-47D3D31B-681A-4AD8-A4EA-BB2FCF6B98EB
P2860
Role of B cells in antigen presentation of the hepatitis B core.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Role of B cells in antigen presentation of the hepatitis B core.
@en
type
label
Role of B cells in antigen presentation of the hepatitis B core.
@en
prefLabel
Role of B cells in antigen presentation of the hepatitis B core.
@en
P2093
P2860
P356
P1476
Role of B cells in antigen presentation of the hepatitis B core.
@en
P2093
P2860
P304
14648-14653
P356
10.1073/PNAS.94.26.14648
P407
P577
1997-12-01T00:00:00Z